SMAD4 and pancreatic ductal adenocarcinoma: In a seminal study by Bardeesy et al, 2006 [46] on genetically engineered mice the impact of SMAD4 deficiency on the initiation, development and/or progression of pancreatic ductal adenocarcinoma (PDAC) was ascertained.